As the Ebola outbreak in West Africa wanes, it is time for the international scientific
community to reflect on how to improve the detection of and coordinated response to future …

Bacteriophage therapy dates back almost a century, but the discovery of antibiotics led to a
rapid decline in the interests and investments within this field of research. Recently, the …

Pig‐to‐human xenotransplantation offers a potential bridge to the growing disparity between
patients with end‐stage organ failure and graft availability. Early studies attempting to …

Glycoprotein D (gD) of Herpes simplex virus (HSV) binds to a host cell surface receptor,
which is required to trigger membrane fusion for virion entry into the host cell. gD has …

Control programs for emerging influenza are in urgent need of novel therapeutic strategies
to mitigate potentially devastating threats from pathogenic strains with pandemic potential …

Defining immunogenic domains of viral proteins capable of eliciting a protective immune
response is crucial in the development of novel epitope‐based prophylactic strategies. This …

Abstract Background Virus-like particles (VLPs) can be efficiently produced by heterologous
expression of viral structural proteins in yeast. Due to their repetitive structure, VLPs are …

Passive immunity is defined as a particular antigen resistance provided by external
antibodies. It can be either naturally or artificially acquired. Natural passive immunization …

This article provides an overview of some aspects of seasonal, pre‐pandemic and pandemic
influenza vaccines and initiatives aimed to increase influenza vaccine use within the A sia–P …

The present study focused on inhibition of HSV-1 and-2 replication and pathogenesis in vitro
and in vivo, through the selective targeting of the envelope glycoprotein D. Firstly, a human …